FFCP PHASE1:Hg19::chr19:50528616..50528670,-
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p1@VRK3 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_VRK3_5end |
Coexpression cluster: | NA |
Association with transcript: | 0bp_to_ENST00000424804, ENST00000443401, uc002prg.2, uc002prl.2, uc010ens.2, uc010ent.1, uc010ybl.1, uc010ybm.1, uc010ybn.1_5end |
EntrezGene: | VRK3 |
HGNC: | 18996 |
UniProt: | E7EMG6B4DGW1Q8IV63 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@VRK3 |
---|
0
10
20
30
40
50
60
70
80
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
hematopoietic cell | 3.01e-14 | 177 |
hematopoietic oligopotent progenitor cell | 1.13e-13 | 161 |
hematopoietic multipotent progenitor cell | 1.13e-13 | 161 |
hematopoietic stem cell | 4.57e-13 | 168 |
myeloid cell | 1.50e-09 | 108 |
common myeloid progenitor | 1.50e-09 | 108 |
hematopoietic lineage restricted progenitor cell | 8.43e-07 | 120 |
leukocyte | 9.74e-07 | 136 |
Showing 1 to 8 of 8 entries
Ontology term | p-value | n |
---|---|---|
leukemia | 1.45e-10 | 39 |
myeloid leukemia | 3.69e-10 | 31 |
hematologic cancer | 6.72e-08 | 51 |
immune system cancer | 6.72e-08 | 51 |
Showing 1 to 4 of 4 entries